e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 10

Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline

Calvin Trieu; Argonde C. van Harten; Mardou S. S. A. van Leeuwenstijn; Lisa‐Marie Schlüter; Lynn Boonkamp; Azzam Aladdin; Sietske A.M. Sikkes; Elsmarieke van de Giessen · 2025 · JAMA Network Open

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Importance: Blood-based biomarkers identify Alzheimer disease and hold promise for monitoring disease progression, even in the preclinical disease stages. Objective: To investigate longitudinal trajectories of blood-based biomarkers and association with cognitive decline and risk of progression in individuals with subjective cognitive decline (SCD). Design, Setting, and Participants: This prospective cohort study (Subjective Cognitive Impairment Cohort) of individuals with SCD evaluated at a memory clinic underwent biennial biomarker collection and annual cognitive assessment and diagnostic ev

Abstract by Calvin Trieu; Argonde C. van Harten; Mardou S. S. A. van Leeuwenstijn; Lisa‐Marie Schlüter; Lynn Boonkamp; Azzam Aladdin; Sietske A.M. Sikkes; Elsmarieke van de Giessen, JAMA Network Open (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1001/jamanetworkopen.2025.45862